Skip Navigation

Neuro-Oncology 2002 4(2):115-122; doi:10.1093/neuonc/4.2.115
© 2002 by Society
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Giordana, M. T.
Right arrow Articles by Chió, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Giordana, M. T.
Right arrow Articles by Chió, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2002 by the Society forNeuro-Oncology

MDM2 overexpression is associated with short survival in adults withmedulloblastoma

Maria Teresa Giordana2, Debora Duó, Sabrina Gasverde, Elisa Trevisan, Andrea Boghi, Isabella Morra, Luca Pradotto, Alessandro Mauro and Adriano Chió

Department of Neuroscience, University of Turin, 10126 Turin,Italy

2 Address correspondence and reprint requests to Maria Teresa Giordana,Department of Neuroscience, University of Turin, Via Cherasco 15, 10126Torino, Italy;mariateresa.giordana{at}unito.it.


   Abstract

In adult medulloblastoma, postoperative radiotherapy is significantlyeffective in prolonging time to recurrence and survival time; however, theresponse of individual cases to radiotherapy, that is the total survival, isdifferent. Apoptosis is an important cellular response to radiation. It can behypothesized that the individual radiosensitivity of medulloblastomas dependson the individual capability to undergo apoptosis. p53 protein is involved inthe apoptotic response to ionizing radiation; loss of function of p53 can bethe consequence not only of TP53 mutations, but also of amplificationand/or overexpression of the MDM2 gene. We have analyzed cerebellarmedulloblastomas from 51 adults (>16 years of age) for MDM2 geneamplification (by differential polymerase chain reaction assay), TP53gene mutation (by polymerase chain reaction single-strand conformationpolymorphism analysis of exons 5-8), and immunohistochemical expression of p53(clone DO1) and MDM2 (clone IF2). The results have been evaluated inrelation to age, tumor location, classic or desmoplastic type, MIB-1 labelingindex, and total survival. No tumor had MDM2 amplification. Tentumors had MDM2-positive tumor cells. One case had a mutatedTP53 gene; 16/51 cases had intense p53 immunostaining. Only 2MDM2 protein-positive tumors were also p53-positive. Both subgroupsof MDM2- and p53-positive tumors had a significantly shorterpostoperative survival. In conclusion, the overexpression of MDM2protein and the accumulation of wild-type p53 are unrelated in adultmedulloblastoma; they may result in a reduced apoptotic response afterradiotherapy and contribute to a shortened survival. Also, MDM2amplification and TP53 gene mutation are rare events inmedulloblastomas of adults.

Received November 19, 2001; Accepted December 20, 2001


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
P.-O. Frappart, Y. Lee, H. R. Russell, N. Chalhoub, Y.-D. Wang, K. E. Orii, J. Zhao, N. Kondo, S. J. Baker, and P. J. McKinnon
Recurrent genomic alterations characterize medulloblastoma arising from DNA double-strand break repair deficiency
PNAS, February 10, 2009; 106(6): 1880 - 1885.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncologyHome page
J. M. de Bont, R. J. Packer, E. M. Michiels, M. L. d. Boer, and R. Pieters
Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective
Neuro Oncology, December 1, 2008; 10(6): 1040 - 1060.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
O. Shakhova, C. Leung, E. van Montfort, A. Berns, and S. Marino
Lack of Rb and p53 Delays Cerebellar Development and Predisposes to Large Cell Anaplastic Medulloblastoma through Amplification of N-Myc and Ptch2.
Cancer Res., May 15, 2006; 66(10): 5190 - 5200.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Lee, H. L. Miller, P. Jensen, R. Hernan, M. Connelly, C. Wetmore, F. Zindy, M. F. Roussel, T. Curran, R. J. Gilbertson, et al.
A Molecular Fingerprint for Medulloblastoma
Cancer Res., September 1, 2003; 63(17): 5428 - 5437.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Q. Yang, D. Senger, H. Muzik, Z. Q. Shi, D. Johnson, P. M. A. Brasher, N. B. Rewcastle, M. Hamilton, J. Rutka, J. Wolff, et al.
Reovirus Prolongs Survival and Reduces the Frequency of Spinal and Leptomeningeal Metastases from Medulloblastoma
Cancer Res., June 15, 2003; 63(12): 3162 - 3172.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. G. Eberhart
Medulloblastoma in Mice Lacking p53 and PARP: All Roads Lead To Gli
Am. J. Pathol., January 1, 2003; 162(1): 7 - 10.
[Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Lee and P. J. McKinnon
DNA Ligase IV Suppresses Medulloblastoma Formation
Cancer Res., November 15, 2002; 62(22): 6395 - 6399.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.